Celebrating the Success of the ILC Symposium 2023!
Thank you for your enthusiastic participation in the ILC Symposium 2023. Your presence, diverse perspectives, and unwavering support played a pivotal role in making the symposium a resounding success. Our thanks to all researchers, patient advocates, and clinicians for their active involvement.
We were honored to have hosted 221 attendees in person and 51 virtually, creating a vibrant global exchange of knowledge. The symposium was enriched by the participation of individuals from 15 different countries, fostering a truly international dialogue.
Together, we’re advancing understanding of ILC, improving treatments, and enhancing support for those affected. We look forward to the positive outcomes and collaborations arising from this symposium.
With warm regards,
Organizing Committee ILC 2023
Watch the recorded sessions below
Thank you to the presenters who agreed to record and share their presentations. Not all presentations were recorded. Please contact the presenters directly with questions. For the complete agenda, click here.
Keynote Speakers
Cathrin Brisken, MD, PhD Swiss Federal Institute of Technology Lausanne (EFPL), Switzerland, Inst. of Cancer Research, London, UK
Stuart Schnitt, MD Dana-Farber Cancer Institute, Boston, MA, USA
Speakers, Chairs, & Moderators
Rohit Bhargava, MD UPMC, Magee-Womens Hospital, Pittsburgh, PA, USA
Val Brunton, PhD University of Edinburgh, Scotland
Giovanni Corso, MD, PhD European Institute of Oncology, University of Milan, Italy
Matt Covington, MD University of Utah, Salt Lake City, UT, USA
The poster PDFs provided here have been shared with the consent of the authors. This collection includes poster PDFs for 29 out of 50 posters, depending on which authors granted permission for their poster PDFs to be published.
We are thrilled to announce the distinguished recipients of the Travel Fellowship for the upcoming ILC Symposium 2023. These exceptional individuals have demonstrated outstanding dedication and contributions to the field of invasive lobular breast cancer research.
Awardees attending from within the USA will receive $800, while international attendees will receive $1200 in fellowship amounts. These fellowships aim to assist participants in covering their expenses and fostering a diverse and inclusive environment for knowledge exchange.
Join us in congratulating the following scholars who have been selected to receive the prestigious Travel Fellowship Award, listed below and here.
Their commitment and passion exemplify the spirit of collaboration and knowledge-sharing that the ILC Symposium stands for. We eagerly anticipate their participation and look forward to their valuable contributions at the symposium. We extend our heartfelt appreciation to all applicants for their exceptional submissions and encourage everyone to be part of this inspiring event.
We are delighted to present the “Digital Toolkit for Advocates” designed exclusively for patient advocates attending the ILC Symposium 2023. This comprehensive toolkit is aimed at enhancing your symposium experience by providing valuable resources and empowering you in your advocacy journey.
Inside the toolkit, you’ll find a treasure trove of resources, including:
๐ฝ๏ธ Video Recordings: Access video recordings of past symposium sessions to catch up on valuable insights shared by renowned experts in the field.
๐ง Instructive Recordings: Dive deeper into instructive sessions that offer valuable tips and advice on patient advocacy, communication, and empowerment.
๐ Links to Advocacy Resources: Discover a curated collection of links to advocacy resources, including Facebook groups and other online platforms where you can connect with like-minded advocates.
๐ก Useful Resources: Find a compilation of valuable resources, documents, and informative materials that can aid you in your advocacy efforts.
This Digital Toolkit is your companion throughout the symposium and beyond, offering a wealth of knowledge and support to enhance your advocacy journey. We hope these resources empower you to make a positive impact in the field of invasive lobular breast cancer research.
Steffi Oesterreich, PhD Chair Professor, Univ of Pittsburgh, Co-Director, Womens Cancer Resarch Center, Co-Leader Cancer Biology Program, UPMC HCC and MWRI
Patrick Derksen, PhD Professor of Experimental & Preclinical Oncology, University Medical Center Utrecht
Rachel C. Jankowitz, MD Associate Professor of Clinical Medicine, University of Pennsylvania, Director of the Rena Rowan Breast Center at Abramson Cancer Center
Rita Mukhtar, MD Associate Professor of Surgery, University of California San Francisco, Principal Investigator of the Lobular Breast Cancer Research Program
Anne Vincent-Salomon, MD, PhD Department Head of Pathology and Pole Coordinator of Pathology-Genomics and Immunology, Institut Curie
Christine Desmedt, PhD Assistant Professor of Oncology, KU Leuven, Head of the Laboratory for Translational Breast Cancer Research
Local Organizing Committee
Daniel D. Brown, PhD Website and Media Manager Senior Research Scientist, Institute for Precision Medicine, University of Pittsburgh/UPMC Hillman Cancer Center Laughing Mantis Studio
Eli Coutch Logistics Coordinator University of Pittsburgh, UPMC Hillman Cancer Center
Jagmohan Hooda, PhD, MBA Symposium Director Senior Research Scientist, University of Pittsburgh, UPMC Hillman Cancer Center
Ken Koncerak Administrator University of Pittsburgh, UPMC Hillman Cancer Center
Adrian V. Lee, PhD Director, Institute for Precision Medicine, Univ. of Pittsburgh and UPMC; Professor of Pharmacology & Chemical Biology and Human Genetics, Univ. of Pittsburgh, Womenโs Cancer Research Center, UPMC Hillman Cancer Center; Magee-Womens Research Institute & Foundation
Priscilla McAuliffe, M.D. PhD Assistant Professor of Surgery, University of Pittsburgh, UPMC Magee Womens Hospital, UPMC Hillman Cancer Center
Nadine Ryan Event Coordinator Administrative Assistant, University of Pittsburgh, UPMC Hillman Cancer Center ryann@upmc.edu
Sucheta Kulkarni, PhD Social Activities Coordinator University of Pittsburgh, UPMC Hillman Cancer Center
GlobMob (Patient Advocate) Organizing Committee
Lori Petitti Co-chair Independent ILC advocate (also: Breast Cancer Care & Research Fund BCCRF)
Claire Turner Co-chair Lobular Breast Cancer UK (LBCUK)
Siobhan Freeney Lobular Ireland
Myiesha Gibson Independent advocate
Judy Hallinen Breast Cancer Research Advocacy Network (bcRAN)
Christine Hodgdon Guiding Researchers & Advocates to Scientific Partnerships (GRASP)
Laurie Hutcheson Lobular Breast Cancer Alliance Inc.
Yen Lam Independent advocate (also: BCRF research campaign)
Julia Katherine Levine Independent ILC advocate (also: Metastatic Lobular Advocate, ILC Symposium FB page, LBCA Lead Research Advocate)
Susan MacDonald Independent ILC advocate (also: Cleveland Clinic Lobular Fund, and LBCA Research Advocate)
Diane Mapes Fred Hutchinson Cancer Center, Seattle, WA, USA; Independent ILC advocate (Two ILC Science & Support FB groups/ILC Symp FB group w/Julia Katherine)
Julia Maues Guiding Researchers & Advocates to Scientific Partnerships (GRASP)
Christine McKay, MSW Canadian Breast Cancer Network (CBCN) Lobular Breast Cancer Ambassador
Flora Migyanka Independent Advocate, ILC and Founder, Dynami Foundation – (LBCA)
Rian Terveer European Lobular Breast Cancer Consortium (ELBCC)
Stephanie Walker Individual MBCl advocate, MBC Alliance-BECOME project, LBBC
Ma’isah Wise Independent advocate
Advisors
Margaret Flowers BCRF
Liz Graves Susan G. Komen
The Assembly
5051 Centre Avenue Pittsburgh, PA 15213
A historical venue to create memories: The ILC symposium 2023 will be held at The Assembly building in Pittsburgh. This is a unique venue with a rich history unlike any other. A century ago, The Assembly was Ford automotiveโs first Model T assembly plant in the US. Over the years the building has become a clothing store and a stationary store. Today, the building has been transformed into a cutting-edge research facility, housing researchers working on cancer and other diseases. We hope this venue will facilitate innovative ideas, new collaboration and relationships, and many priceless memories. Read more on the fascinating history of the venue here: The Assembly: A former Model T factory builds the next generation of cancer treatments.
(Photo credits: The University of Pittsburgh & the Lee/Oesterreich Laboratory)
Then and now
(Photo credits: Wexford Science and Technology, University of Pittsburgh & The Henry Ford)
